NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
This grant opportunity funds Phase I clinical trials for diagnosing and treating heart, lung, blood, and sleep (HLBS) disorders. It covers the beginning stages, implementation, and late preclinical activities of these trials, which can take place at one or multiple sites. The funding will be awarded in two phases, based on reaching specific milestones.
The objective of this funding opportunity will be to support investigator-initiated, Phase 0 and I clinical trials (including bridging studies) for diagnosis and therapeutic interventions (e.g., drugs, devices, and biologics, including cells and cell products) for heart, lung, blood, and sleep (…
Funding Source
Awards & funding
Eligibility
Foreign/Non-domestic entities: Non-domestic (non-U.S.) Entities (Foreign Organizations) are NOT eligible to apply. However, non-domestic (non-U.S.) components of U.S. organizations are eligible to apply, and foreign components (as defined in the NIH Grants Policy Statement) are allowed within ap…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers